WORCESTER, MA -- (MARKET WIRE) -- May 17, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that the Ministry of Economy and Trade Intellectual Property Protection Office in Lebanon granted the Company a second Lebanese patent titled, “Orally Absorbed Pharmaceutical Formulation and Method of Administration.”
